Thursday, April 2, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

What concerns you most about your healthcare?

For each statement below, please select the number that best reflects your feelings.

 

 I worry that artificial intelligence in medical diagnostics may produce errors that harm patients.
I am uneasy about my health data privacy when using telehealth and digital health apps.
 Rising use of GLP-1 weight-loss medications (e.g., Ozempic) off-label makes me concerned about supply and costs.
 Recent changes to vaccine policy and expert panels (e.g., CDC ACIP appointments) undermine my confidence.
 I feel anxious about the long-term effects of disposable vape toxins on personal and environmental health.
 The expansion of remote patient monitoring via wearables raises concerns about data security and accuracy.
 I am concerned that tick-borne diseases will spread to new regions due to climate change.
 I worry about mental health apps and VR therapy replacing in-person counseling without adequate oversight.
The environmental footprint of healthcare (e.g., medical waste, energy use) is a serious sustainability issue.
 I am apprehensive about robotic-assisted surgery errors and how complications differ from human-performed operations.
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Videos

Policy Shift in Peptide Regulation

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide and the Expansion Problem: When One Trial Becomes a Platform

Semaglutide has moved beyond its original indication and now sits at the center of a widening set of clinical questions: cardiovascular risk, kidney disease progression, and even neurodegeneration. The question is no longer whether the drug lowers glucose or reduces weight—it does—but how far those effects extend across systems, and whether evidence from one population can be translated into another without distortion. Large, well-powered trials have produced consistent signals, yet those signals are now being applied in contexts that were...

Read more

Join Our Newsletter!